H.C. Wainwright maintains RVL Pharmaceuticals at 'buy' with a price target of $3.00

  • Investing.com
H.C. Wainwright maintains RVL Pharmaceuticals at 'buy' with a price target of $3.00

An analyst from H.C. Wainwright maintained RVL Pharmaceuticals (NASDAQ: RVLP ) at 'buy' with a price target of $3.00 from a prior price target of $4.00.

Prior to this rating, RVL Pharmaceuticals had 3 buy ratings, 1 hold ratings, and 0 sell ratings.

For consensus analyst estimates and price targets on RVL Pharmaceuticals, click here. For more news on RVL Pharmaceuticals, click here.

RVL Pharmaceuticals's stock price closed at $0.1600. They are down -62.66% in the last month and down -92.2900% in the last 12 months.

According to Investing Pro, RVL Pharmaceuticals's fair value is $0.2127, an upside of 33.3826%. RVL Pharmaceuticals's fair value comes with a high degree of uncertainty, according to InvestingPro.

Check out RVL Pharmaceuticals's recent earnings performance and financials here.

Drop an image here or Supported formats: *.jpg, *.png, *.gif up to 5mb

Error: File type not supported

Drop an image here or

100